MYRIAD GENETICS INC — Director's Dealing 2015

Jul 2, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-07-01

Reporting Person: Ford Alexander (President, MGL)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3031	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Incentive Stock Option (right to buy)	$15.98	2020-06-22	Common Stock (4000)		Direct
Incentive Stock Option (right to buy)	$18.0	2021-02-23	Common Stock (11000)		Direct
Incentive Stock Option (right to buy)	$19.47	2021-09-13	Common Stock (5449)		Direct
Incentive Stock Option (right to buy)	$23.98	2022-03-07	Common Stock (1000)		Direct
Incentive Stock Option (right to buy)	$26.49	2021-09-17	Common Stock (3775)		Direct
Incentive Stock Option (right to buy)	$27.07	2022-09-12	Common Stock (2808)		Direct
Non-Qualified Stock Option (right to buy)	$19.47	2021-09-13	Common Stock (10551)		Direct
Non-Qualified Stock Option (right to buy)	$23.98	2022-03-07	Common Stock (3000)		Direct
Non-Qualified Stock Option (right to buy)	$26.49	2021-09-17	Common Stock (51225)		Direct
Non-Qualified Stock Option (right to buy)	$27.07	2022-09-12	Common Stock (32192)		Direct

Footnotes

F1: Vests 25% a year over four years - initial vesting 9/13/12, final vesting 9/13/15

F2: Vests 25% a year over four years - initial vesting 3/7/13, final vesting 3/7/16

F3: Vests 25% a year over four years - initial vesting 9/17/14, final vesting 9/17/17

F4: Vests 25% a year over four years - initial vesting 9/12/13, final vesting 9/12/16